Immediate Impact

51 standout
Sub-graph 1 of 24

Citing Papers

Pre-metastatic niche: formation, characteristics and therapeutic implication
2024 Standout
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
2 intermediate papers

Works of Eric Schaefer being referenced

A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer
2021
A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer and Systemic Inflammation
2018

Author Peers

Author Last Decade Papers Cites
Eric Schaefer 130 75 226 190 35 450
Norma Quintanilla 63 148 193 100 31 498
Monica T. Garcia 109 63 183 92 29 444
Marianne Wigger 118 67 82 96 24 495
Patrick Fauré 97 53 162 175 27 421
Fukuzo Matsuya 113 160 161 43 31 441
Umberto Tedeschi 62 87 255 103 34 463
Jessica X. Yu 72 72 226 66 44 420
Giacomo Sarzo 118 76 244 102 30 403
Shuyi Wei 100 46 95 80 29 459
K.-H. Shu 50 86 148 76 38 486

All Works

Loading papers...

Rankless by CCL
2026